Synthon Pharmaceuticals, Inc.
Filing
58
ORDER granting 57 Motion to Substitute Party. Mylan Pharmaceuticals Inc. added. Synthon Pharmaceuticals, Inc. terminated. Signed by Chief Judge James C. Dever III on 8/1/2017. (Briggeman, N.)
UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF NORTH CAROLINA
WESTERN DIVISION
SYNTHON PHARMACEUTICALS, INC. [to be
substituted out]; MYLAN PHARMACEUTICALS
INC. [to be substituted in]
CIVIL ACTION NO:
5:10-cv-00150-D
Plaintiffs,
v.
ELI LILLY and COMPANY and ICOS
CORPORATION,
Defendants.
CIVIL ACTION NO.
ELI LILLY AND COMPANY and, ICOS
CORPORATION,
5: 10-cv -0402-D
Plaintiffs,
v.
SYNTHON PHARMACEUTICALS INC. [to be
substituted out]; MYLAN PHARMACEU'IJCALS
INC. [to be substituted in]
Defendants.
ORDER SUBSTITUTING MYLAN PHARMACEUTICALS INC.
FOR SYNTHON PHARMACEUTICALS, INC.
THIS MATTER is before the Court on the Stipulated Motion for Consent Order
Substituting Mylan Pharmaceuticals Inc. for Synthon Pharmaceuticals, Inc. filed by all parties. It
appears to the Court that good cause exists to grant the Motion.
WHEREFORE, the Stipulated Motion for Consent Order Substituting Mylan
Pharmaceuticals Inc. for Synthon Pharmaceuticals, Inc. is hereby GRANTED.
IT
IS
HEREBY
ORDERED,
ADJUDGED,
AND
DECREED
that
Mylan
Pharmaceuticals Inc. is substituted for Synthon Pharmaceuticals, Inc. as Plaintiff in Civil Action
No.
5:10-cv-00150-D
and
Mylan
Pharmaceuticals
Inc.
is
substituted
for
Synthon
Pharmaceuticals, Inc. as Defendant in 5:10-cv-0402-D.
SO ORDERED. This
A~'iusf
_t_day of JotttY2017.
Chief United States District Judge
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?